TITLE

Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study

AUTHOR(S)
Beer, Beate; Schubert, Birthe; Oberguggenberger, Anne; Meraner, Verena; Hubalek, Michael; Oberacher, Herbert
PUB. DATE
October 2010
SOURCE
Analytical & Bioanalytical Chemistry;Oct2010, Vol. 398 Issue 4, p1791
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There is substantial evidence that circulating estrogens promote the proliferation of breast cancer. Consequently, adjuvant hormonal treatment strategies targeting estrogen action have been established. Such hormonal therapies include selective estrogen receptor modulators, such as tamoxifen, which interfere at the estrogen receptors directly, or non-steroidal aromatase inhibitors, such as anastrozole and letrozole, which inhibit estrogen synthesis through blocking the aromatase, a key enzyme of estrogen production. Despite considerable therapeutic success, in several cases, the use of these drugs is limited by side effects that have been described to significantly impair the adherence of patients to endocrine treatment. However, objective data concerning patient adherence and its clinical relevance are limited. One promising approach to check patient-reported adherence is drug monitoring in human plasma. Therefore, a liquid chromatography-tandem mass spectrometry method to determine the plasma concentrations of tamoxifen, anastrozole, and letrozole has been developed and fully validated according to guidelines for clinical and forensic toxicology. The validation criteria evaluated were selectivity, linearity, accuracy and precision, limit of quantification, recovery and matrix effects, sample stability, and carryover. The six-point calibration curves showed linearity over the range of concentrations from 25 to 500 ng/ml for tamoxifen, 5 to 200 ng/ml for anastrozole, and 10 to 300 ng/ml for letrozole. The intra- and inter-day precision and accuracies were always better than 15%. The validated procedure was successfully applied to a clinical study (Patient-Reported Outcomes in Breast Cancer Patients undergoing Endocrine Therapy, PRO-BETh). A major aim of PRO-BETh study is the comprehensive evaluation of adherence to treatment in pre- and post-menopausal women with breast cancer. Plasma samples of 310 breast cancer patients undergoing anti-estrogen therapy were analyzed. Eight samples did not contain a quantifiable amount of drug, strongly indicating non-adherence of the corresponding patients to adjuvant breast cancer treatment. Furthermore, plasma concentrations at the lower end of the observed plasma level distribution might represent a hint but not a confirmation for non-adherence in terms of non-daily and irregular intake of the prescribed drug.
ACCESSION #
53840428

 

Related Articles

  • Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer. Gaikwad, Nilesh W.; Li Yang; Pruthi, Sandhya; Ingle, James N.; Sandhu, Nicole; Rogan, Eleanor G.; Cavalieri, Ercole L. // Breast Cancer: Basic & Clinical Research;2009, Issue 3, p1 

    Endogenous estrogens can be bio-activated to endogenous carcinogens via formation of estrogen quinones. Estrogen-3,4-quinones react with DNA to form mutagenic depurinating estrogen-DNA adducts. The carcinogenicity of endogenous estrogens is related to unbalanced estrogen metabolism leading to...

  • Ceramide synthases and ceramide levels are increased in breast cancer tissue. Schiffmann, Susanne; Sandner, Jessica; Birod, Kerstin; Wobst, Ivonne; Angioni, Carlo; Ruckhäberle, Eugen; Kaufmann, Manfred; Ackermann, Hanns; Lötsch, Jörn; Schmidt, Helmut; Geisslinger, Gerd; Grösch, Sabine // Carcinogenesis;May2009, Vol. 30 Issue 5, p745 

    Several in vitro studies have correlated dysfunction of the sphingolipid-signaling pathway with promotion of tumor cell growth as well as progression and resistance of tumors to chemotherapeutic agents. As ceramides (Cer) constitute the structural backbones of all sphingolipids, we investigated...

  • VALIDATION AND APPLICATION OF A HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY- TANDEM MASS SPECTROMETRY ASSAY FOR LETROZOLE IN HUMAN PLASMA. JOSHI, CHIDAMBARA; VISHNUBHATLA, SHIVAPRSAD; CHAKKIRALA, SATYENDRANATH; MANNAM, SUBBARAO // Asian Journal of Pharmaceutical & Clinical Research;Apr2011, Vol. 4 Issue 2, p107 

    A simple, rapid, sensitive and specific liquid chromatography-tandem mass spectrometry method was developed and validated for quantification of letrozole (I), non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery. The analyte and internal...

  • Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry. Kim, Hanna; Min, Hye Kyeong; Kong, Gu; Moon, Myeong Hee // Analytical & Bioanalytical Chemistry;Mar2009, Vol. 393 Issue 6/7, p1649 

    Phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs) from urine of patients with breast cancer were qualitatively and quantitatively analyzed by nanoflow liquid chromatography-electrospray ionization tandem mass spectrometry (nLC-ESI-MS-MS). Urinary phospholipids (PLs) were extracted...

  • Introduction. Howell, T. // British Journal of Cancer;3/1/2004 Supplement, Vol. 90, pS1 

    Introduces four papers that together provide a comprehensive review of fulvestrant, a new type of endocrine agent for the treatment of hormone-sensitive advanced breast cancer in postmenopausal women. Importance of using different endocrine agents with different mechanisms of action that do not...

  • Chemical and Bioassay Analysis of Estrogen Pollution in the Surface Water of the Tiaoxi River, the Source River for Taihu Lake. Tang, Xianjin; Ullah, Naveed; Yu, Chunna; Qin, Zhihui; Huang, Ronglang; Zhu, Xiaolou; Shen, Chaofeng; Chen, Yingxu // Bulletin of Environmental Contamination & Toxicology;Oct2012, Vol. 89 Issue 4, p816 

    The estrogen pollution in the Tiaoxi River, which is the main source river for Taihu Lake, was investigated by chemical and bioassay analysis. Most estrogens species, except estrone, were not detected by the chemical analysis using liquid chromatography coupled with tandem mass spectrometry. The...

  • Simultaneous Determination of Hormonal Residues in Treated Waters Using Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry. Guedes-Alonso, Rayco; Sosa-Ferrera, Zoraida; Santana-Rodríguez, José Juan // Journal of Analytical Methods in Chemistry;2013, p1 

    In the last years, hormone consumption has increased exponentially. Because of that, hormone compounds are considered emerging pollutants since several studies have determinted their presence in water influents and effluents of wastewater treatment plants (WWTPs). In this study, a quantitative...

  • Fulvestrant and the sequential endocrine cascade for advanced breast cancer. Johnston, S. // British Journal of Cancer;3/1/2004 Supplement, Vol. 90, pS15 

    Following relapse on endocrine therapy for advanced, hormone receptor-positive breast cancer, it is common for patients to experience responses to alternative endocrine agents. Fulvestrant (‘Faslodex’) is a new type of endocrine treatment - an oestrogen receptor (ER) antagonist with...

  • Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Xin Pan; Tao Zhou; Yan-Hong Tai; Chenguang Wang; Jie Zhao; Yuan Cao; Yuan Chen; Pei-Jing Zhang; Ming Yu; Cheng Zhen; Rui Mu; Zhao-Fang Bai; Hui-Yan Li; Ai-Ling Li; Bing Liang; Zhao Jian; Wei-Na Zhang; Jiang-Hong Man; Yan-Fei Gao; Wei-Li Gong // Nature Medicine;Jun2011, Vol. 17 Issue 6, p708 

    Endocrine resistance is a major obstacle to hormonal therapy for breast cancers. Although reduced expression of estrogen receptor-α (ER-α) is a known contributing factor to endocrine resistance, the mechanism of ER-α downregulation in endocrine resistance is still not fully understood....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics